Mayo Finds Little Evidence that DTC Tests Stir Risk Worries | GenomeWeb

By Matt Jones

NEW YORK (GenomeWeb News) – Genetic tests sold directly to consumers that provide predictions on disease risk have made some personalized medicine watchers wary that these tests could cause unnecessary psychological stress and worry among customers about their risk of disease, but a new study from Mayo Clinic suggests that those worries may be minimal.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.